Liver toxicity and pioglitazone: Data are missingBMJ 2004; 329 doi: http://dx.doi.org/10.1136/bmj.329.7471.918 (Published 14 October 2004) Cite this as: BMJ 2004;329:918
- Peshraw Amin ([email protected]), consultant endocrinologist
- Derby Royal Infirmary Hospital, Derby DE1 2QY
EDITOR—The interesting drug point by Farley-Hills et al, on fatal liver failure associated with pioglitazone, is missing data.1 I hope that it will remind doctors to monitor liver function and not cause a scare similar to that which …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial